VRNA
Verona Pharma
VRNA
VRNA
12 hedge funds and large institutions have $79.3M invested in Verona Pharma in 2017 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 1 closing their positions.
Holders
12
Holders Change
+2
Holders Change %
+20%
% of All Funds
0.27%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.05%
New
3
Increased
3
Reduced
1
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
VP
1
venBio Partners
San Francisco,
California
|
$10.4M |
| 2 |
O
2
OrbiMed
New York
|
$14.8M |
| 3 |
PC
3
Polar Capital
London,
United Kingdom
|
$1.13M |
| 4 |
4
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
$7K |
Top Sellers
| 1 |
FCMI
1
Foresite Capital Management III
Larkspur,
California
|
$6.27M |
| 2 |
TRCT
2
Tower Research Capital (TRC)
New York
|
$0 |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
VC
1
Vivo Capital
Palo Alto,
California
| $17.7M | 1,492,951 | – | – |
|
|
O
2
OrbiMed
New York
| $14.8M | 1,250,396 | +583,730 | +88% |
|
|
NMC
3
NEA Management Company
Timonium,
Maryland
| $14.5M | 1,219,674 | – | – |
|
|
VP
4
venBio Partners
San Francisco,
California
| $10.4M | 875,000 | +875,000 | New |
|
|
NHAS
5
Novo Holdings A/S
Hellerup,
Denmark
| $8.79M | 740,740 | – | – |
|
|
FCMI
6
Foresite Capital Management III
Larkspur,
California
| $6.27M | 528,422 | -80,429 | -13% |
|
|
TCM
7
Tekla Capital Management
Boston,
Massachusetts
| $3.28M | 275,000 | – | – |
|
|
PA
8
Perceptive Advisors
New York
| $2.38M | 200,000 | – | – |
|
|
PC
9
Polar Capital
London,
United Kingdom
| $1.13M | 95,149 | +19,232 | +25% |
|
|
10
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| $7K | 600 | +600 | New |
|
|
TRCT
11
Tower Research Capital (TRC)
New York
| – | – | -199 | Closed |
|
12
UBS Group
Zurich,
Switzerland
| $0 | 1 | +1 | New |
|
13
Morgan Stanley
New York
| $0 | 15 | +1 | +7% |
|